Imperva Inc (IMPV) 47.68 $IMPV Insider Trading Alert -

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Imperva Inc (IMPV) 47.68 $IMPV

Insider Trading Alert - HEB, MS And IMPV Traded By Insiders
at The Street - Wed Apr 22, 9:15AM CDT
Stocks with insider trader activity include HEB, MS and IMPV
HEB: 0.25 (+0.01), IMPV: 47.68 (-0.88), MS: 37.20 (+0.45)

Cybersecurity stocks rally after Fortinet beats estimates, guides strong
Seeking Alpha - at Seeking Alpha - Tue Apr 21, 12:35PM CDT

HACK: 30.39 (+0.14), PFPT: 58.45 (-0.45), CYBR: 65.53 (-0.84), ZIXI: 4.27 (+0.14), CUDA: 45.71 (-0.08), QLYS: 52.38 (-0.77), IMPV: 47.68 (-0.88), PANW: 153.87 (-0.50), FTNT: 38.07 (-0.01)

Imperva Honored as Winner in the Third Annual 2015 Cyber Defense Magazine Awards in Two Categories
GlobeNewswire - Mon Apr 20, 8:00AM CDT
Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, announced today that Cyber Defense Magazine, the industry's leading electronic information security magazine and media partner of the RSA(R) Conference 2015, has named Imperva Skyfence Cloud Gateway winner of the Most Innovative Cloud Security Solution for 2015 and Imperva SecureSphere winner of the Most Innovative Data Center Security Solution for 2015.
IMPV: 47.68 (-0.88)

Imperva Teams With IS Group to Bring Imperva Incapsula Cloud Services to Dutch Market
Marketwired - Thu Apr 16, 8:01AM CDT
Imperva Inc. (NYSE: IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced that it has entered into an agreement with IS (Interned Services) Group, a Dutch leader in cloud computing and IT services, to bring Imperva Incapsula cloud services for DDoS mitigation, Web application firewall (WAF), content delivery network (CDN) and load balancing to the Dutch market. IS Group builds and manages business-critical cloud and ICT (Information and Communication Technology) solutions for its over 30,000 customers that depend on uptime and performance of their websites and online applications. By reselling Incapsula services, IS Group clients can boost their Web application security, improving their websites' performance and accessibility.
IMPV: 47.68 (-0.88)

[Podcast] When will this hedge-fund-hotel stock crack?
ESTMZ - Tue Apr 14, 4:25PM CDT
This week’s episode features Rob DeFrancesco , a veteran Estimize contributor and the managing editor of TechStockProspector.com. On this podcast Leigh and Rob break down what the momentum behind Palo Alto Networks means for the stock, they...
NOW: 77.72 (+0.22), FEYE: 43.67 (+0.18), QLIK: 33.68 (+0.31), MKTO: 28.84 (+0.98), NMBL: 24.61 (-0.13), ZEN: 23.61 (-0.19), RKUS: 12.44 (-0.09), IMPV: 47.68 (-0.88), PANW: 153.87 (-0.50)

Global cyberattacks surge in 2014
Seeking Alpha - at Seeking Alpha - Tue Apr 14, 5:22AM CDT

HACK: 30.39 (+0.14), VDSI: 25.11 (-0.58), FEYE: 43.67 (+0.18), PFPT: 58.45 (-0.45), CYBR: 65.53 (-0.84), CUDA: 45.71 (-0.08), PANW: 153.87 (-0.50), FTNT: 38.07 (-0.01), IMPV: 47.68 (-0.88), CHKP: 87.17 (+0.48)

PANW/FEYE top Piper security checks; PFPT/FTNT/IMPV underperform
Seeking Alpha - at Seeking Alpha - Mon Apr 13, 3:44PM CDT

HACK: 30.39 (+0.14), FEYE: 43.67 (+0.18), PFPT: 58.45 (-0.45), CUDA: 45.71 (-0.08), IMPV: 47.68 (-0.88), FTNT: 38.07 (-0.01), PANW: 153.87 (-0.50)

Palo Alto Networks A Top Pick For Security Stocks
at Investor's Business Daily - Mon Apr 13, 1:03PM CDT
Palo Alto Networks (PANW) and FireEye topped the list of security stocks in a survey of resellers and distributors across the U.S. and Europe. Other security companies that did well in a survey of more than three dozen distributors included Barracuda...
FEYE: 43.67 (+0.18), PFPT: 58.45 (-0.45), CYBR: 65.53 (-0.84), CUDA: 45.71 (-0.08), EMC: 27.13 (+0.81), NTAP: 36.14 (+0.14), IMPV: 47.68 (-0.88), FTNT: 38.07 (-0.01), PANW: 153.87 (-0.50), ORCL: 43.55 (+0.13), SYMC: 24.36 (+0.26)

3 Reasons Growth Stock Investors Will Love Imperva (IMPV) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 7:38AM CDT
Imperva (IMPV) has a favorable growth score and it is ranked as a buy too. This means that we believe Imperva stock is a potential outperformer that is an impressive choice for growth investors, making it a security that you need to keep on your radar in the near term.
IMPV: 47.68 (-0.88)

Imperva Announces Enhancements to Its Incapsula Cloud Service to Extend Enterprise Capabilities to Organizations of All Sizes
Marketwired - Thu Apr 09, 8:00AM CDT
Imperva Inc. (NYSE: IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced updates to Imperva Incapsula, its cloud-based application delivery service. These additions include a turnkey integration with leading security information and event management (SIEM) tools, external monitoring of network infrastructures, and multi-protocol DDoS protection for dedicated customer IP addresses. Combined, these new enhancements bring advanced security capabilities to organizations of all sizes, without the need to augment security and networking teams.
IMPV: 47.68 (-0.88)

Imperva to Report First Quarter 2015 Financial Results
Business Wire - Mon Apr 06, 7:30AM CDT
Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today announced that it will report financial results for the first quarter ended March 31, 2015 after the close of the market on May 7, 2015.
IMPV: 47.68 (-0.88)

Cybersecurity stocks slump; Obama authorizes cyberattack sanctions
Seeking Alpha - at Seeking Alpha - Wed Apr 01, 1:57PM CDT

HACK: 30.39 (+0.14), FEYE: 43.67 (+0.18), PFPT: 58.45 (-0.45), FTNT: 38.07 (-0.01), IMPV: 47.68 (-0.88), PANW: 153.87 (-0.50)

Cybersecurity stocks rally; House committee approves bill
Seeking Alpha - at Seeking Alpha - Thu Mar 26, 1:44PM CDT

HACK: 30.39 (+0.14), VDSI: 25.11 (-0.58), FEYE: 43.67 (+0.18), PFPT: 58.45 (-0.45), CYBR: 65.53 (-0.84), QLYS: 52.38 (-0.77), IMPV: 47.68 (-0.88), FTNT: 38.07 (-0.01), PANW: 153.87 (-0.50)

Imperva Releases Latest Hacker Intelligence Initiative Report: Attacking SSL When Using RC4
GlobeNewswire - Thu Mar 26, 8:00AM CDT
Imperva, Inc. (NYSE:IMPV), committed to protecting business-critical data and applications in the cloud and on-premises, today released its latest Hacker Intelligence Initiative (HII) report, "Attacking SSL when using RC4: Breaking SSL with a 13-year old RC4 Weakness." Authored by the company's Application Defense Center (ADC) research team, the report reveals new attack vulnerabilities on the popular Transport Layer Security (TLS/SSL) protocol, which is currently used to protect as many as 30 percent of all SSL transactions, a number that may equate up to billions of TLS connections per day.
IMPV: 47.68 (-0.88)

Recent Developments in Computer Software Companies: Special Research on HubSpot, Imperva, Imprivata, IntraLinks, and King Digital
PR Newswire - Tue Mar 24, 6:40AM CDT
Editor Note: For more information about this release, please scroll to bottom.
IMPR: 14.75 (-0.11), IL: 10.10 (+0.12), IMPV: 47.68 (-0.88), KING: 17.19 (-0.13), HUBS: 39.16 (-1.12)

Notable tech gainers/decliners: IMPV, CSLT, ROVI, KNDI, DRWI, XOOM
Seeking Alpha - at Seeking Alpha - Wed Mar 18, 2:05PM CDT

KNDI: 12.22 (+0.11), MX: 5.61 (-0.03), DRWI: 0.76 (+0.03), DMD: 6.60 (+0.10), SGI: 9.45 (+0.27), ZEN: 23.61 (-0.19), CSLT: 7.85 (+0.36), IMPV: 47.68 (-0.88), SIMO: 33.64 (+0.15), XOOM: 15.95 (+0.18), ROVI: 19.46 (+0.10)

IMPERVA WELCOMES ALASTAIR CORBETT AS NEW REGIONAL VICE PRESIDENT OF EMEA
Thomson Reuters ONE - Tue Mar 17, 7:00AM CDT

IMPV: 47.68 (-0.88)

3 Unusual-Volume Tech Stocks to Trade for Breakouts
at The Street - Fri Mar 13, 12:50PM CDT
These tech stocks rising on unusual volume are within range of triggering breakout trades.
MBLY: 47.47 (+0.93), IMPV: 47.68 (-0.88), IMOS: 24.00 (+0.47)

Imperva up 5% after pricing offering
Seeking Alpha - at Seeking Alpha - Fri Mar 13, 11:14AM CDT

IMPV: 47.68 (-0.88)

Imperva Announces Pricing of Follow-on Offering
Business Wire - Thu Mar 12, 6:51PM CDT
Imperva, Inc. (NYSE: IMPV) today announced the pricing of its underwritten registered public follow-on offering of 3,000,000 shares of its common stock at a price to the public of $39.00 per share. Imperva also granted the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock. The offering is expected to close on March 18, 2015, subject to customary closing conditions.
DB: 33.95 (+0.61), IMPV: 47.68 (-0.88), MS: 37.20 (+0.45)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading